Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:focusesOn |
immuno-oncology
|
| gptkbp:foundedIn |
2013
|
| gptkbp:founder |
gptkb:Jeremy_Myers
gptkb:Juan_Jaen gptkb:Terry_Rosen |
| gptkbp:headquartersLocation |
gptkb:San_Carlos,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flexus Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableFor |
developing IDO1 inhibitors
|
| gptkbp:website |
https://www.flexusbiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Brook_Byers
|
| gptkbp:bfsLayer |
6
|